Literature DB >> 21668580

Thymosin β₄ knockdown disrupts mitochondrial functions of SW480 human colon cancer cells.

Mei-Chuan Tang1, Yeu Su.   

Abstract

Thymosin β(4) (Tβ(4)), overexpressed in various tumors, has been shown to be involved in cellular anti-oxidation. Reactive oxygen species (ROS) function as signaling molecules and play certain roles in tumor progression. To assess the anti-oxidative role of endogenous Tβ(4) in tumor cells, its expression in SW480 cells was knocked down by a shRNA, which induced significant increases of ROS. Interestingly, some cristae-lost and several electron-dense mitochondria appeared in cells with Tβ(4) knockdown that was accompanied by a marked decline of the membrane potential of these organelles. Strikingly, while the ATP and lactate levels in SW480 cells were notably elevated by Tβ(4) downregulation, this treatment significantly diminished the mitochondrial DNA copy number and protein levels of several subunits of the electron transport complexes. Finally, immunofluorescent staining results suggested the presence of Tβ(4) in mitochondria. To the best of our knowledge, this is the first report to demonstrate that Tβ(4) knockdown can disrupt the morphology and some crucial functions of mitochondria in human colorectal carcinoma (CRC) cells.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668580     DOI: 10.1111/j.1349-7006.2011.02002.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  2 in total

1.  In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA.

Authors:  T-C Chao; L-C Chan; S-Y Ju; M-C Tang; C-Y Liu; P-M Chen; C-H Tzeng; Y Su
Journal:  Cancer Gene Ther       Date:  2014-08-15       Impact factor: 5.987

2.  Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.

Authors:  Li-Hsing Chi; Wei-Min Chang; Yu-Chan Chang; Yung-Chieh Chan; Chia-Chen Tai; Kam-Wing Leung; Chi-Long Chen; Alexander Th Wu; Tsung-Ching Lai; Yu-Chuan Jack Li; Michael Hsiao
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.